MAS1/RG expression was highly significantly reduced in BSV–VI compared to BS0–II (p < .001) and was lower in BSV–VI when calibrated against all 3 cell-surface markers (p < .0001 for all) indicating a global reduction in MAS1 gene expression in end-stage AD (Figure 3F). This evidence concerns the gene MAS1 and Alzheimer disease.